Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by drippingsnoton Sep 04, 2020 4:24pm
216 Views
Post# 31511844

RE:For the long time homies...

RE:For the long time homies...So I sit and wait.

You said a lot of things but they almost seem like there were opposing thoughts.
You said investors won't be putting their money in ATE - sounds bad.
You also say you are obsessed with ATE's success and 2021 will change everyone's life - that's good to me.
Did I misunderstand ?

As we saw recently, Big Pharma isn't afraid to lay down the cash ... even at during this time.
We also know ATE made no bones about their interest in offloading the first drug and letting Big Pharma take it through Phase 3 - gotta get through Phase 2 first.

If ATE does their job (with the amazing data that accompanies the first drug), they could make a sale - assuming with the help of 5 leprachauns).  If we get even luckier (say with the help of 20 leprachauns) we could even see a pharma make a run at us.  With about 5 more lprachauns we could see a few pharmas battle it out for the patents (and new patents - if we're lucky).

All possible without going to any exchange or without the markets getting interested in ATE.

Then again, should we be unlucky - then we go it alone, we go to a US exchange and we find a bunch of smaller partnerships to help us get through.

All possible at this time - I'm thinking.
<< Previous
Bullboard Posts
Next >>